Xtx Topco LTD Cytek Biosciences, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 115,401 shares of CTKB stock, worth $437,369. This represents 0.02% of its overall portfolio holdings.
Number of Shares
115,401
Previous 170,279
32.23%
Holding current value
$437,369
Previous $682,000
42.52%
% of portfolio
0.02%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding CTKB
# of Institutions
156Shares Held
73.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$64.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$29.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.11MShares$26.9 Million0.72% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$25.2 Million0.93% of portfolio
-
State Street Corp Boston, MA4.17MShares$15.8 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $510M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...